STAT+: Experts critique flawed system for monitoring drugs’ side effects in wake of asthma drug report
STAT
JANUARY 31, 2024
and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address. Experts say that the Singulair incident highlights a flawed system, both in the U.S. “The question is, how safe do you want to be?” “Are we at the right balance?
Let's personalize your content